Hologic Inc. closed 23.86% short of its 52-week high of $84.67, which the company reached on August 9th.
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...
9h
Zacks.com on MSNDeciphering Hologic (HOLX) International Revenue TrendsHave you evaluated the performance of Hologic's (HOLX) international operations for the quarter ending December 2024? Given the extensive global presence of this medical device maker, analyzing the ...
The WTA’s audience soared to new heights during the 2024 season as fans around the world watched the drama unfold across more ...
Hologic lowered its fiscal 2025 revenue forecast, citing weakness in sales of its breast health products, sending the company's shares down 5% after the bell on Wednesday.
Q1 2025 Earnings Conference Call February 5, 2025 4:30 PM ETCompany ParticipantsMike Watts - Corporate Vice President, ...
Raymond James lowered the firm’s price target on Hologic (HOLX) to $90 from $95 and keeps an Outperform rating on the shares. Hologic’s print ...
In the first major shakeup of the WTA 1000 season, Marta Kostyuk took down World No. 3 Coco Gauff with a straight-sets ...
Hologic, Inc. (NASDAQ:HOLX – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Thursday after Leerink Partnrs downgraded the stock from a strong-buy rating to a hold ...
MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Hologic Inc. (HOLX) on Wednesday reported fiscal first-quarter profit of $201 million. On a per-share basis, the Marlborough, Massachusetts-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results